Add BrightSurf on Google Email

Largest-ever genetic study of fibromyalgia points to a neurological origin of the disorder and opens the door to new treatments

A landmark study identifies new genetic risk factors associated with fibromyalgia syndrome, pointing to a neurological origin of the disorder. The research found substantial overlap between fibromyalgia and other conditions, suggesting shared biological mechanisms that may benefit from targeted therapies.

SourceLunenfeld-Tanenbaum Research Institute·JournalNature Medicine·TypeData/statistical analysis·DateJul 28, 2026

Researchers map genetics of blood lipids with unprecedented precision

A study published in Nature Communications identified over 50 previously unknown genes that affect lipid composition in the human body. These findings may provide a better understanding of aging processes and pathological conditions such as Alzheimer's disease, diabetes, and cardiovascular dysfunctions.

SourceDZNE - German Center for Neurodegenerative Diseases·JournalNature Communications·TypeObservational study·DateMay 19, 2026

Fondazione Telethon’S Genomic Program end the diagnostic odissey for hundreds of children

The program achieved a definitive genetic diagnosis in nearly half of enrolled children, identifying pathogenic variants across 330 genes. Families received timely diagnoses, allowing accurate genetic counseling and informed reproductive choices, while guiding clinical management and opening access to targeted therapies.

SourceFondazione Telethon·JournalGenetics in Medicine Open·TypeExperimental study·DateApr 20, 2026

Largest genetic study of schizophrenia and African ancestry reveals shared biology across global populations

A recent study published in Nature identified over 100 new genetic regions linked to schizophrenia that had not been previously discovered. These findings show that while specific genetic variants may differ across populations, the core biological mechanisms underlying schizophrenia are shared worldwide.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature·TypeObservational study·DateJan 21, 2026

Chinese scientists reveal how isoflavone 6-hydroxylase mediates soybean resistance to Phytophthora sojae

Researchers discovered the biosynthetic pathway of glycitein, a key soybean isoflavonoid, and its role in plant immunity. They found that GmIF6H1 enzyme catalyzes the production of glycitein, which acts synergistically with glyceollins to defend soybeans against infection by Phytophthora sojae.

SourceChinese Academy of Sciences Headquarters·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 11, 2025

Genomic maps untangle the complex roots of disease

Researchers develop comprehensive method to connect diseases with underlying genetic machinery, revealing intricate gene networks that influence complex traits. The new technique provides actionable insights into how specific genes affect cell functions, shedding light on biological mechanisms and potential therapeutic targets.

SourceGladstone Institutes·JournalNature·DateDec 10, 2025

New technique maps genetic variants driving neurodegenerative disease risk

A new method developed by Penn State researchers improves the analysis of genetic data, identifying more genes associated with neurodegenerative diseases like Alzheimer's and ALS. The technique, BASIC, integrates both bulk tissue samples and single-cell data to uncover shared genetic effects across different cell types.

SourcePenn State·JournalNature Communications·TypeData/statistical analysis·DateDec 2, 2025

King’s College London researcher advances psychiatric genomics through pioneering polygenic scoring innovations

Dr Oliver Pain develops GenoPred platform advancing personalized mental healthcare worldwide through accessible genetic tools, democratizing access to cutting-edge genomic methodologies. His work aims to reduce global health inequities by developing inclusive polygenic scoring methods that perform accurately across all ancestry groups.

SourceGenomic Press·JournalGenomic Psychiatry·TypeNews article·DateSep 9, 2025

Potential to prevent and treat a common type of inflammatory arthritis advanced by the identification of new genetic links

Researchers have identified two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition disease in Americans of European and African descent. This discovery opens up promising new avenues for targeted prevention and treatment of CPPD disease, which is currently lacking effective options.

SourceElsevier·JournalAnnals of the Rheumatic Diseases·TypeData/statistical analysis·DateMay 28, 2025

FOXP4 gene identified in the first large-scale genetic study on Long COVID with participation of the GCAT

A large-scale genetic study identified the FOXP4 gene as a significant factor in Long COVID, linked to lung health and immune response. The study found a strong relationship between severe COVID-19 cases and Long COVID, highlighting potential biological factors contributing to the condition.

SourceGermans Trias i Pujol Research Institute·JournalNature Genetics·TypeMeta-analysis·DateMay 22, 2025

Largest ever genome-wide association study uncovers new drug targets and potential therapies for osteoarthritis

A recent study has made a breakthrough in understanding the genetic underpinnings of osteoarthritis by identifying 962 genetic markers associated with the condition. The researchers found 513 new genetic markers that were not previously reported, providing potential new drug targets and opportunities for repurposing existing medications.

SourceUniversity of Maryland School of Medicine·JournalNature·TypeMeta-analysis·DateApr 15, 2025

Genetic predisposition to sedentary behavior increases the risk of cardiovascular diseases

A new study found that genetic predisposition to sedentary behavior is associated with a higher risk of developing the most common cardiovascular diseases. Individuals with the highest genetic predisposition accumulated more daily sedentary time and had a 20% higher risk of cardiovascular diseases.

SourceUniversity of Jyväskylä - Jyväskylän yliopisto·JournalBritish Journal of Sports Medicine·DateApr 8, 2025

Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer—insights from two-sample Mendelian randomization study and meta-analysis

A genetic predisposition to type II diabetes mellitus is associated with a reduced risk of esophageal cancer. Metformin use has been shown to decrease the prevalence of esophageal cancer, while insulin and gliclazide have no significant association.

SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateFeb 25, 2025

Identified 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease

A recent study has identified 51 amyotrophic lateral sclerosis (ALS)-associated mutations in mitochondrial DNA that could help diagnose the disease. The mutations, which include 13 that increase the risk of ALS and 38 protective ones, were found to be significantly associated with an increased or decreased risk of developing the disease.

New study emphasizes the importance of genetics in gout research

Researchers have identified new pathogenic pathways in gout through a genome-wide association analysis, providing promising targets for the prevention and treatment of this painful form of arthritis. The study highlights the importance of genetics in gout research and offers potential insights into other illnesses and disorders.

SourceUniversity of Alabama at Birmingham·JournalNature Genetics·TypeData/statistical analysis·DateOct 25, 2024

Study busts myths about cause of gout

A genome-wide association study found that inherited genetics is a key factor in why some people develop gout, while others don't. The research identified new targets for preventing gout attacks and hopes to lead to improved treatment options.

SourceUniversity of Otago·JournalNature Genetics·DateOct 15, 2024

How cells control gene expression by cleaning up their mistakes

Cells produce three times as many 'unproductive' transcripts with mistakes or unexpected configurations as they do steady-state, finished RNA. These unproductive transcripts are quickly destroyed by a cellular process called nonsense-mediated decay (NMD), which suggests the cell intentionally makes mistakes to regulate gene expression....

SourceUniversity of Chicago·JournalNature Genetics·TypeData/statistical analysis·DateSep 2, 2024

Researchers unveil shared and unique brain molecular dysregulations in PTSD and depression

A comprehensive study by McLean Hospital researchers reveals both shared and unique molecular changes across brain regions, genomic layers, cell types, and blood in individuals with posttraumatic stress disorder (PTSD) and major depressive disorder (MDD). The findings provide potential avenues for novel therapeutics and biomarkers.

SourceMcLean Hospital·JournalScience·TypeData/statistical analysis·DateMay 23, 2024